Key facts
- This page summarizes Mika K. Derynck's Form 4 filing for Enliven Therapeutics, Inc. (ELVN).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 06 Aug 2026, 20:18.
Mika K. Derynck - 04 Aug 2026 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)
- Reporting relationship
- Director
- Issuer ticker
- ELVN
- Reported as of
- 04 Aug 2026
- Net transaction value
- -$9,561,587
- SEC form
- 4
- Accepted by SEC
- 06 Aug 2026, 20:18:03 UTC
- Prior SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ben Hohl, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mika K. Derynck filed Form 4 for Enliven Therapeutics, Inc. (ELVN) on 06 Aug 2026.
Change
- Previous filing in this sequence was filed on 17 Feb 2026.
- Current net transaction value: -$9,561,587.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001865125
Primary reporting owner
Derynck Mika K
- Relationship
- Director
- Address
- C/O ENLIVEN THERAPEUTICS, INC., 205 PARK ROAD, BURLINGAME
- Signature
- /s/ Ben Hohl, by power of attorney
- Signature date
- 06 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +87,373
- Change %
- Price
- $2.48*
- Shares after
- 87,373
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +27,567
- Change %
- +32%
- Price
- $25.28*
- Shares after
- 114,940
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +23,364
- Change %
- +20%
- Price
- $14.85*
- Shares after
- 138,304
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
ELVN
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +20,491
- Change %
- +15%
- Price
- $22.47*
- Shares after
- 158,795
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
ELVN
transaction
Common Stock
Sale
- Transaction value
- $9,561,587
- Shares
- -158,795
- Change %
- -100%
- Price
- $60.21
- Shares after
- 0
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -87,373
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 87,373
- Exercise price
- $2.48
- Footnotes
- F1, F3
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -27,567
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,567
- Exercise price
- $25.28
- Footnotes
- F1, F3
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -23,364
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,364
- Exercise price
- $14.85
- Footnotes
- F1, F3
ELVN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -20,491
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,491
- Exercise price
- $22.47
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 8, 2025.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $60.00 to $60.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Footnote F3
All of the shares subject to this option are fully vested and exercisable as of the date hereof.